Furthermore, lots of nicely set up adverse prognostic markers, like U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, dropped their destructive outcome in people addressed with VO. The only variable that remained predictive of the shorter progression-free of charge survival During this cohort of patients was TP53 aberrations.112 Finally, the choice